Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02004522 |
|---|---|
| Brief Title: | A Phase 3 Study of Duvelisib Versus Ofatumumab in Patients With Relapsed or Refractory CLL/SLL (DUO) |
| First Submitted : | November 13, 2013 |
| First Submitted that Met QC Criteria : | December 3, 2013 |
| First Posted : | December 9, 2013 (Estimate) |
| Results First Submitted : | October 23, 2018 |
| Results First Submitted that Met QC Criteria : | January 4, 2019 |
| Results First Posted : | January 8, 2019 |
| Certification/Extension First Submitted : | July 30, 2018 |
| Certification/Extension First Submitted that Met QC Criteria : | July 30, 2018 |
| Certification/Extension First Posted : | August 1, 2018 |
| Last Update Submitted that Met QC Criteria : | September 7, 2023 |
| Last Update Posted : | September 21, 2023 |